By MARI YAMAGUCHI
TOKYO (AP) — Japan’s prime minister announced Wednesday an additional $800 million contribution to the U.N.-backed initiative to provide COVID-19 vaccines to poor countries, a four-fold increase of Japanese funding for the COVAX program.
The pledge by Prime Minister Yoshihide Suga comes as his government attempts to accelerate vaccinations in Japan, one of the world’s least inoculated countries, only about 50 days before it hosts the Olympics amid a continuing surge in infections.
He spoke as Japan co-sponsored a fundraising event for COVAX with Gavi, the Vaccine Alliance, which helps run the program. The program managers are seeking about $2 billion more to reach a target of $8.3 billion for its effort to fund free vaccines for low- and middle-income countries around the world.
“Now is the time for us to act,” Suga said, leading a parade of world and humanitarian leaders who announced pledges and commitments on Wednesday. He said the additional $800 million will bring Japan’s contribution to $1 billion, second to the $2.5 billion pledged by the United States.
Suga also announced plans to provide 30 million doses of a vaccine manufactured under license in Japan to other countries in need. He did not specify the maker or recipients.
Officials have said Japan is considering providing the AstraZeneca vaccine to Taiwan as the island faces a resurgence of infections.
Japan has approved three foreign-developed vaccines and is currently using ones from Pfizer Inc. and Moderna Inc. It has no immediate plans to use the AstraZeneca vaccine, which is easier to store and transport than the other two vaccines, which require special freezers, officials said.
The summit was also attended by U.S. Vice President Kamala Harris, Australian Prime Minister Scott Morrison, U.N. Secretary General Antonio Guterres and philanthropist Bill Gates.
Globally, more than 3.5 million people are confirmed to have died from the coronavirus. The U.S. has seen the largest confirmed loss of life from COVID-19, at more than 594,000 people.
A man receives the Pfizer COVID-19 vaccine at the Noevir Stadium Kobe in Kobe, western Japan, Monday, May 31, 2021. The stadium is being used as an inoculation venue for local residents over 65 years old. Japan, seriously behind in coronavirus vaccination efforts, is scrambling to boost daily shots as the start of the Olympics in July closes in. (Yu Nakajima/Kyodo News via AP)